Summit Global Investments Astrazeneca PLC Transaction History
Summit Global Investments
- $1.57 Billion
- Q3 2024
A detailed history of Summit Global Investments transactions in Astrazeneca PLC stock. As of the latest transaction made, Summit Global Investments holds 53,892 shares of AZN stock, worth $3.83 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
53,892Holding current value
$3.83 Million% of portfolio
0.27%Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,343Shares Held
492MCall Options Held
4.99MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$4.62 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.03 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$2.89 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.61 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.25 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $220B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...